Collaboration for success: the value of strategic col-laborations for precision medicine and biomarker discovery
Vol 1, Issue 1, 2016, Article identifier:25-33
VIEWS - 1881 (Abstract) 442 (PDF)
Abstract
Keywords
Full Text:
PDFReferences
Landeck L, Kneip C, Reischl J, et al. 2015, Biomarkers and personalized medicine: current status and further perspectives with special focus on dermatology, in Experimental Dermatology. (In press)
Scannell J W, Blanckley A, Boldon H, et al. 2012, Diagnosing the decline in pharmaceutical R&D efficiency. Nature Reviews Drug Discovery, vol.11: 191–200.
Arrowsmith J, 2011, Phase II failures: 2008–2010. Nature Reviews Drug Discovery, vol.10: 328–329.
Salter H and Holland R, 2014, Biomarkers: refining diagnosis and expediting drug development — reality, aspiration and the role of open innovation. Journal of Internal Medicine, vol.276: 215–228.
Bettegowda C, Sausen M, Leary R J, et al. 2014, Detection of circulating tumor DNA in early- and late-stage human malignancies. Science Translational Medicine, vol.6: 224.
Diehl F, Li M, He Y, et al. 2006, BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions. Nature Methods, vol.3: 551–559.
Lessl M, Bryans J S, Richards D, et al. 2011, Crowd sourcing in drug discovery. Nature Reviews Drug Discovery, vol.10: 241–242.
Wellenreuther R, Keppler D, Mumberg D, et al. 2012, Promoting drug discovery by collaborative innovation: A novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer Health-Care. Drug Discovery Today, vol.17: 1242–1248.
Lessl M, Schoepe S, Sommer A, et al. 2011. Grants-4targets — an innovative approach to translate ideas from basic research into novel drugs. Drug Discovery Today, vol.16: 288–292.
Dorsch H, Jurock A E, Schoepe S, et al. 2015, Grants4Targets — an open innovation initiative to foster drug discovery collaborations between academia and the pharmaceutical industry. Nature Reviews Drug Discovery, vol.14: 74–76.
Schmitz A A, Hackethal S, Schulz A, et al. 2015, Phar-ma compound sharing with academia: experiences with providing Vitamin D receptor ligands. Nature Reviews Drug Discovery, vol.14: 294–296.
Asadullah K, Busch A, Gottwald G, et al. 2015, Industrial–academic collaborations for biomarkers. Nature Reviews Drug Discovery, vol.14: 805–806.
Wholley D, 2014, The biomarkers consortium. Nature Reviews Drug Discovery, vol.13: 791–792.
Stephenson D, Sauer J M, 2014, The predictive safety testing consortium and the coalition against major diseases. Nature Reviews Drug Discovery, vol.13: 793–794.
Lessl M, Douglas F, 2010, From technology-transfer to know-how interchange. Wissenschaftsmanagement, vol.(2): 34–41.
DOI: http://dx.doi.org/10.18063/APM.2016.01.002
(1881 Abstract Views, 442 PDF Downloads)
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Lilla Landeck, Monika Lessl, Joachim Reischl, Andreas Busch, Patricia Carrigan, Matthias Gottwald, Petra Reinke, Khusru Asadullah

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
| Advances in Precision Medicine is a peer-reviewed, open-access journal. All journal content, except where otherwise noted, is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |